NMR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nomura Holdings Inc (NMR) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. While there are some positive indicators such as bullish moving averages and an upgrade from JPMorgan, the pre-market price drop of -2.77%, declining financial metrics, and lack of significant trading signals suggest that this is not an optimal entry point. Holding off for now is recommended.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200) and a positive MACD histogram (0.106), indicating an upward trend. However, the RSI at 74.61 is in the neutral zone, and the pre-market price is down -2.77%, suggesting caution.
JPMorgan upgraded the stock to Overweight with a slightly increased price target, citing undervaluation and strong core business.
Bullish moving averages and positive MACD histogram.
Pre-market price drop of -2.77%.
Declining financial performance in Q3 2026, with net income down -10.73% YoY and EPS down -9.09% YoY.
No recent news or significant trading trends from hedge funds, insiders, or Congress.
In Q3 2026, revenue increased 1.39% YoY, but net income dropped -10.73% YoY, and EPS fell -9.09% YoY. Gross margin improved by 7.23% to 44.93%. Overall, financial performance shows mixed results with declining profitability.
JPMorgan upgraded Nomura to Overweight from Neutral with a price target increase from 1,430 yen to 1,440 yen, citing undervaluation and strong core business fundamentals.
